Ultomiris 1100 mg/11mL (Ravulizumab SOLUTION, CONCENTRATE) 1100 mg/11mL

Ultomiris 1100 mg/11mL is a solution concentrate used for intravenous administration. This medication, containing ravulizumab, is designed to target specific conditions related to complement-mediated disorders. Learn more about its uses and effects.

Strength

1100 mg/11mL

Pack Size

1 VIAL, GLASS in 1 CARTON (25682-028-01) / 11 mL in 1 VIAL, GLASS

Manufacturer / TM Owner

Alexion Pharmaceuticals Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ultomiris 1100 mg/11mL is primarily used to manage certain complement-mediated disorders. Ravulizumab, the active ingredient, works by inhibiting the complement system, which plays a role in the body's immune response. This medication is often prescribed for conditions where the complement system is overactive, leading to various health issues. What is Ultomiris used for? It is commonly used in the treatment of conditions such as paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).

Side Effects

Common effects of Ultomiris 1100 mg/11mL may include infusion-related reactions, which can manifest as symptoms like headache, nausea, or fever. Some individuals may also experience fatigue or dizziness. These effects are generally mild and temporary, but it is important to monitor any persistent or severe reactions and consult a healthcare provider if necessary.

Precautions & Warnings

Ultomiris 1100 mg/11mL should be handled with care, ensuring proper storage and administration. It is crucial to follow the prescribed dosage and administration guidelines provided by a healthcare professional. Patients should inform their healthcare provider about any existing medical conditions or allergies before starting this medication. Additionally, regular monitoring may be required to assess the medication's effectiveness and safety.

Avoid Interactions

Ultomiris 1100 mg/11mL may interact with other medications, particularly those that affect the immune system or blood clotting. It is important to inform your healthcare provider about all medications, including over-the-counter drugs and supplements, that you are taking. Alcohol consumption should be discussed with a healthcare provider, as it may affect the medication's efficacy or increase the risk of side effects.

Frequently Asked Questions

Ultomiris is used to manage certain complement-mediated disorders, such as paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).

Ultomiris is administered intravenously by a healthcare professional. The solution concentrate is diluted and infused into the bloodstream.

Common side effects may include infusion-related reactions such as headache, nausea, fever, fatigue, and dizziness.

It is important to inform your healthcare provider about all medications you are taking, as Ultomiris may interact with other drugs, especially those affecting the immune system or blood clotting.

Ultomiris should be stored according to the manufacturer's guidelines, typically in a refrigerator at a controlled temperature. Always follow the storage instructions provided with the medication.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.